Case for Water Stewardship in the Biopharma Sector

This document is a case study that discusses the necessity of shifting to water stewardship within the biopharmaceutical sector. It outlines the critical role that clean water plays in the production of monoclonal antibody drugs and vaccines, emphasizing the industry's dependence on high-quality water sources. The case study presents the challenges posed by climate change, pollution, and increasing demand for water, which necessitate a change in how the industry approaches water management. It highlights the barriers to wider action, including a focus on internal efficiency rather than broader water risks. The document defines water stewardship as a socially equitable, environmentally sustainable, and economically beneficial approach to water use, advocating for a shift from traditional water management to stewardship that considers local water basins. It also discusses the importance of risk evaluation and the need for companies to incorporate water resilience into their business practices to mitigate water-related risks.